West Virginia House Bill HB4312

West Virginia 2026 Regular Session

• Introduced: 1/14/26
• Refer: 1/14/26
• Refer: 1/30/26

Caption

Relating to authorizing the Board of Pharmacy to promulgate a legislative rule relating to pharmacy permits.

Summary

House Bill 4312 authorizes the West Virginia Board of Pharmacy to promulgate a legislative rule concerning pharmacy permits. The bill amends and reenacts a section of the West Virginia Code that lists agency rules approved for legislative authorization, and specifically approves the Board of Pharmacy rule identified as 15 CSR 15, which was filed, modified to address objections from the Legislative Rule-Making Review Committee, and refiled in October 2025. In practical terms, the bill does not itself create a new permitting system in statute; rather, it gives legal effect to the Board’s administrative rule governing pharmacy permits. This means the Board of Pharmacy would be able to implement and enforce the permit-related requirements contained in the rule under its existing authority, and pharmacies and other regulated parties subject to permit requirements would need to comply with the approved rule framework.

Impact

HB4312 affects West Virginia’s administrative rulemaking process by authorizing a specific Board of Pharmacy rule under Chapter 64, Article 9 of the state code. Its main legal impact is to validate the pharmacy-permit rule as a legislative rule, allowing the Board of Pharmacy to proceed with regulation of pharmacy permits under 15 CSR 15. The bill primarily affects the Board of Pharmacy and regulated pharmacy operators, permit applicants, and other entities subject to pharmacy permitting requirements.

Sentiment

The available record suggests little overt controversy or debate around HB4312. Because there are no committee transcripts or recorded votes included, the bill appears to be a routine administrative authorization measure rather than a contested policy proposal. The overall sentiment is best characterized as neutral and procedural, focused on approving a rule that had already been reviewed and revised to address legislative objections.

Contention

No specific points of contention are documented in the provided materials. The only identifiable issue is the underlying pharmacy-permit rule itself, which had been modified to meet objections from the Legislative Rule-Making Review Committee before being refiled. That suggests any concerns were addressed during the rule review process rather than through public debate on the bill text itself.